| Financial Year |
March 31 2023 |
| Monetary Funds |
2,094,873,691.11 |
| Held-for-trading Financial Assets |
1,787,278,744.57 |
| Notes Receivable |
1,219,342,900.26 |
| Accounts Receivable |
1,398,378,581.38 |
| Advances to Suppliers |
79,983,450.84 |
| Other Receivables |
6,342,750.21 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,109,958,996.29 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,942,485.50 |
| Total Current Assets |
8,707,101,600.16 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
2,698,347,795.89 |
| Under-construction Projects |
713,115,871.17 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
439,190,974.96 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
107,272,227.84 |
| Deferred Income Tax Assets |
29,714,866.28 |
| Other Non-Current Assets |
153,384,626.47 |
| Sub-Total of Non-Current Assets |
4,442,005,452.38 |
| Total Assets |
13,149,107,052.54 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,691,939,108.71 |
| Accounts Payable |
1,786,790,672.53 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
87,560,526.37 |
| Taxes Payable |
161,609,871.72 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
9,247,854.97 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,008,646.84 |
| Other Current Liabilities |
28,101,154.66 |
| Sub-Total of Current Liabilities |
3,778,104,287.97 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
187,114,215.23 |
| Special Payable |
-- |
| Estimatied Liabilities |
48,995,039.96 |
| Deferred Income Tax Liabilities |
19,003,025.38 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
676,242,918.55 |
| Total Liabilities |
4,454,347,206.52 |
| Paid-In Capital(Or Share Stock) |
285,679,419.00 |
| Capital Surplus |
4,176,293,293.63 |
| Surplus Reserve |
179,346,065.82 |
| LESS:Treasury Stock |
42,381,499.42 |
| Undistributed Profits |
4,073,501,271.24 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,694,759,846.02 |
| Owner's Equity（Stockholder's Equity） |
8,694,759,846.02 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,149,107,052.54 |
